Inside Financial Markets

Abbott Laboratories Pakistan Reports Rs. 1.5 Billion Profit – Result Preview

Karachi: On the back of strong quarterly performance, Abbott Laboratories Pakistan reports that it boosted in net earnings by nearly a tenth during six months ending on June 30, 2015, the company’s financial results revealed on Monday.

The maker of Mospel, a mosquito repellant, reported an after-tax profit of Rs1.5 billion or Rs. 15 per share in the first half of 2015, up 11% compared to Rs1.3 billion or Rs13.6 per share it earned in the same period last year.

The revenues for the period increased by 5% to Rs9.8 billion compared to Rs9.3 billion it grossed during the first six months of 2014, according to a notice sent to the Karachi Stock Exchange.

On a quarterly basis, the results were even better as the company’s earnings increased by 30% to Rs909 million or Rs9.3 per share compared to Rs697 million or Rs7.12 per share it earned in the April-June quarter of 2014. 

Baqar Hussain

A Wannabe CFO, just had stepped in the corporate sector, willing to explore every aspect here and learn as mush as i can, awareness for those who dont, get the info where ever possible and stay up to date always.

Add comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

The Canadian Securities Institute


CSI is part of Moody's Analytics Learning Solutions, which offers educational programs and credentials throughout the world.

Email Newsletter

Subscribe to receive inspiration, news, and ideas in your inbox.

Inside Financial Markets was a joint publication of Pakistan Stock Exchange (PSX)and Society of Technical Analysts Pakistan (STAP)